B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells

References

• Ma H, Wu X, Tao M, et al. Efficacy and safety of bevacizumab-based maintenance therapy in metastatic colorectal cancer: a meta-analysis. Medicine (Baltimore). 2019;98(50):e18227.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu Y, Zhang Q, et al. Exosomal long non-coding RNA HOTTIP increases resistance of colorectal cancer cells to mitomycin via impairing MiR-214-Mediated degradation of KPNA3. Front Cell Dev Biol. 2020;8:582723.
   PubMed Web of Science ®Google Scholar
• Joung JG, Oh BY, Hong HK, et al. Tumor heterogeneity predicts metastatic potential in colorectal cancer. Clin Cancer Res. 2017;23(23):7209–7216.
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer. Lancet. 2019;394(10207):1467–1480.
   PubMed Web of Science ®Google Scholar
• Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 2003;18(6):849–861.
   PubMed Web of Science ®Google Scholar
• Prasad DV, Richards S, Mai XM, et al. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity. 2003;18(6):863–873.
   PubMed Web of Science ®Google Scholar
• Li J, Lee Y, Li Y, et al. Co-inhibitory molecule B7 superfamily member 1 expressed by tumor-infiltrating myeloid cells induces dysfunction of anti-tumor CD8(+) T cells. Immunity. 2018;48(4):773–786 e775.
   PubMed Web of Science ®Google Scholar
• Gruosso T, Gigoux M, Manem VSK, et al. Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers. J Clin Invest. 2019;129(4):1785–1800.
   PubMed Web of Science ®Google Scholar
• Krambeck AE, Thompson RH, Dong H, et al. B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival. Proc Natl Acad Sci U S A. 2006;103(27):10391–10396.
   PubMed Web of Science ®Google Scholar
• Zhu J, Chu BF, Yang YP, et al. B7-H4 expression is associated with cancer progression and predicts patient survival in human thyroid cancer. Asian Pac J Cancer Prev. 2013;14(5):3011–3015.
   PubMedGoogle Scholar
• Xie N, Cai JB, Zhang L, et al. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma. Cell Death Dis. 2017;8(12):3205.
   PubMedGoogle Scholar
• Li C, Zhan Y, Ma X, et al. B7-H4 facilitates proliferation and metastasis of colorectal carcinoma cell through PI3K/Akt/mTOR signaling pathway. Clin Exp Med. 2020;20(1):79–86.
   PubMed Web of Science ®Google Scholar
• Brabletz T, Kalluri R, Nieto MA, et al. EMT in cancer. Nat Rev Cancer. 2018;18(2):128–134.
   PubMed Web of Science ®Google Scholar
• Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14(10):611–629.
   PubMed Web of Science ®Google Scholar
• Smit MA, Peeper DS. Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY). 2010;2(10):735–741.
   PubMedGoogle Scholar
• Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–1428.
   PubMed Web of Science ®Google Scholar
• Zhao G, Zhang W, Dong P, et al. EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFbeta pathway. Cell Biosci. 2021;11(1):70.
   PubMed Web of Science ®Google Scholar
• Chen HY, Chiang YF, Huang JS, et al. Isoliquiritigenin reverses epithelial-mesenchymal transition through modulation of the TGF-beta/Smad signaling pathway in endometrial cancer. Cancers (Basel). 2021;13:6.
   Web of Science ®Google Scholar
• Li J, Zhang Z, Feng X, et al. Stanniocalcin-2 promotes cell EMT and glycolysis via activating ITGB2/FAK/SOX6 signaling pathway in nasopharyngeal carcinoma. Cell Biol Toxicol. 2021; DOI:10.1007/s10565-021-09600-5.
   Web of Science ®Google Scholar
• Kong PZ, Yang F, Li L, et al. Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor. PLoS One. 2013;8(4):e61591.
   PubMed Web of Science ®Google Scholar
• Yu Y, Xiao CH, Tan LD, et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-beta signalling. Br J Cancer. 2014;110(3):724–732.
   PubMed Web of Science ®Google Scholar
• Sun L, Zheng W, Liu QD, et al. Valproic Acid Protects Chondrocytes from LPS-Stimulated damage via regulating miR-302d-3p/ITGB4 axis and mediating the PI3K-AKT signaling pathway. Front Mol Biosci. 2021;8:633315.
   PubMed Web of Science ®Google Scholar
• Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2(6):442–454.
   PubMed Web of Science ®Google Scholar
• Chen Y, Sun J, Zhao H, et al. The coexpression and clinical significance of costimulatory molecules B7-H1, B7-H3, and B7-H4 in human pancreatic cancer. Onco Targets Ther. 2014;7:1465–1472.
   PubMed Web of Science ®Google Scholar
• Shrestha R, Prithviraj P, Anaka M, et al. Monitoring immune checkpoint regulators as predictive biomarkers in hepatocellular carcinoma. Front Oncol. 2018;8:269.
   PubMed Web of Science ®Google Scholar
• Huang H, Li C, Ren G. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer. Gene. 2017;623:24–28.
   PubMed Web of Science ®Google Scholar
• Wang P, Li C, Zhang F, et al. Clinical value of combined determination of serum B7-H4 with carcinoembryonic antigen, osteopontin, or tissue polypeptide-specific antigen for the diagnosis of colorectal cancer. Dis Markers. 2018;(2018:4310790.
   PubMed Web of Science ®Google Scholar
• Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia. 2010;15(2):117–134.
   PubMed Web of Science ®Google Scholar
• Fragiadaki M, Mason RM. Epithelial-mesenchymal transition in renal fibrosis - evidence for and against. Int J Exp Pathol. 2011;92(3):143–150.
   PubMed Web of Science ®Google Scholar
• Su J, Zhang A, Shi Z, et al. MicroRNA-200a suppresses the Wnt/beta-catenin signaling pathway by interacting with beta-catenin. Int J Oncol. 2012;40(4):1162–1170.
   PubMed Web of Science ®Google Scholar
• Mongroo PS, Rustgi AK. The role of the miR-200 family in epithelial-mesenchymal transition. Cancer Biol Ther. 2010;10(3):219–222.
   PubMed Web of Science ®Google Scholar
• Sawyer WT, Leventhal E, Collins M. Comment: kCl formulations. Drug Intell Clin Pharm. 1987;21(10):836–838.
   PubMedGoogle Scholar
• Wang J, Xia X, Tao X, et al. Knockdown of carbohydrate sulfotransferase 12 decreases the proliferation and mobility of glioblastoma cells via the WNT/beta-catenin pathway. Bioengineered. 2021;12(1):3934–3946.
   PubMed Web of Science ®Google Scholar
• Yang B, Wang F, Zheng G. Transmembrane protein TMEM119 facilitates the stemness of breast cancer cells by activating Wnt/beta-catenin pathway. Bioengineered. 2021;12(1):4856–4867.
   PubMed Web of Science ®Google Scholar
• Zhang L, Ren R, Yang X, et al. Oncogenic role of early growth response-1 in liver cancer through the regulation of the microRNA-675/sestrin 3 and the Wnt/beta-catenin signaling pathway. Bioengineered. 2021;12(1):5305–5322.
   PubMed Web of Science ®Google Scholar
• Zhou X, Mao Y, Zhu J, et al. TGF-beta1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis. Oncotarget. 2016;7(41):67196–67211.
   PubMedGoogle Scholar
• Jiang Y, Cai G, Lin J, et al. B7-H4 is highly expressed in aggressive Epstein-Barr virus positive diffuse large B-cell lymphoma and inhibits apoptosis through upregulating Erk1/2 and Akt signalling pathways. Infect Agent Cancer. 2019;14(1):20.
   PubMed Web of Science ®Google Scholar
• Hao TT, Liao R, Lei DL, et al. Inhibition of B7-H4 promotes hepatocellular carcinoma cell apoptosis and autophagy through the PI3K signaling pathway. Int Immunopharmacol. 2020;88:106889.
   PubMed Web of Science ®Google Scholar
• Timmermans-Sprang EP, Gracanin A, Mol JA. High basal Wnt signaling is further induced by PI3K/mTor inhibition but sensitive to cSRC inhibition in mammary carcinoma cell lines with HER2/3 overexpression. BMC Cancer. 2015;15(1):545.
   PubMedGoogle Scholar
• Huang TS, Li L, Moalim-Nour L, et al. A Regulatory Network Involving beta-Catenin, e-Cadherin, PI3k/Akt, and slug balances self-renewal and differentiation of human pluripotent stem cells in response to wnt signaling. Stem Cells. 2015;33(5):1419–1433.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang N, Li A, et al. Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway. Cancer Lett. 2020;485:14–26.
   PubMed Web of Science ®Google Scholar
• Yuan L, Ye J, Fan D. The B7-H4 gene induces immune escape partly via upregulating the PD-1/Stat3 pathway in non-small cell lung cancer. Hum Immunol. 2020;81(5):254–261.
   PubMed Web of Science ®Google Scholar
• Wu H, Wang X, Mo N, et al. B7-Homolog 4 promotes epithelial-mesenchymal transition and invasion of bladder cancer cells via activation of nuclear factor-kappaB. Oncol Res. 2018;26(8):1267–1274.
   PubMed Web of Science ®Google Scholar